Project Grant HT9425261E178
Award Date 6/1/26
Completion Date 5/31/29
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10022, USA
Similar Awards
- Federal Grant Award Summary Weill Medical College of Cornell University received a $1,482,860 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2029. The award supports research focused on pharmacological targeting of ubiquitin ligase UBR5 for breast cancer immunotherapy applications. This research initiative aligns with the Defense Health Agency's portfolio of basic and applied...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $1,685,582 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2028. The award supports research and development of theranostic TROP-2-directed pretargeted radioimmunotherapy for metastatic disease. This three-year initiative combines diagnostic and therapeutic capabilities targeting TROP-2 antigen...
- Grant Award Summary Weill Medical College of Cornell University received a $988,740 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on June 15, 2025, with completion scheduled for June 14, 2028. The project, titled "Genomically Informed Morphological Stromal Signatures to Predict Lethal Prostate Cancer," focuses on developing innovative diagnostic and predictive tools for prostate cancer. This research...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $1.75M project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2029. The award supports research investigating the circulating antibody repertoire and blood-brain barrier impairment as mechanisms underlying neuropsychiatric symptoms associated with invisible brain injury. This research aligns with...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $669,400 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion scheduled for August 31, 2029. The grant supports research investigating the biological mechanisms and therapeutic relevance of the SLC1A1 amino acid transporter in kidney cancer. This four-year research initiative is positioned within the...
- Federal Grant Award Summary Albert Einstein College of Medicine received a $1.25 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective April 1, 2026, through March 31, 2029. The award supports research into immunosuppressive mechanisms in breast cancer stem cells to develop new immunotherapy approaches. This three-year research initiative will be conducted at the institution's facilities in the...
- Grant Award Summary Albert Einstein College of Medicine received a $1,249,920 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded April 1, 2026, with an ultimate completion date of March 31, 2029. The award supports research to unravel immunosuppressive mechanisms in breast cancer stem cells for development of new immunotherapy approaches. This three-year research initiative addresses critical oncology and...
- Federal Grant Award Summary Weill Medical College of Cornell University received a $553,189 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2029. The research initiative, titled "Circulating Antibody Repertoire and Blood-Brain-Barrier Impairment to Explain Neuropsychiatric Symptoms of 'Invisible' Brain Injury," will be conducted at the institution's New...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with a performance period from July 1, 2026 through June 30, 2029. The award funds research to identify novel therapeutic targets that overcome treatment resistance in triple-negative breast cancer (TNBC), a particularly aggressive form of cancer with limited...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Wistar Institute of Anatomy and Biology a $750,000 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The award supports the development of novel biologic therapeutics targeting Siglec-7/9 receptors designed to activate and engage natural killer (NK) cells and macrophages for the treatment of advanced breast cancer. This research...